Product Program year 2025 Source: CMS Open Payments

R2p Misago

Device Lesion Therapy

PDI 04987350727749

Open in the dashboard

General payments

$328,485

1,549 payments

Research payments

$0

0 payments

Through program year 2025, $328,485 in general payments and $0 in research payments were reported against R2p Misago (Lesion Therapy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $21,280 296
2024 General $21,465 193
2023 General $21,851 171
2022 General $143,947 421
2021 General $119,941 468

Breakdown

Who paid General payments · program years 2021–2025
  1. Terumo Medical Corporation $328,485 1,549 payments
Top recipients General payments · program year 2025
  1. Ankur Lodha Interventional Cardiology · Lafayette, LA $2,237 11% · 3 payments
  2. Constantino Pena Diagnostic Radiology · Miami, FL $1,200 6% · 1 payment
  3. Herrick Wun Vascular Surgery · New York, NY $900 4% · 1 payment
  4. Parag Patel Interventional Cardiology · Safety Harbor, FL $573 3% · 2 payments
  5. Celso Dias Vascular Surgery · Rochester, NY $450 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $7,957 38% · 63 practitioners
  2. Interventional Cardiology Internal Medicine $6,165 30% · 35 practitioners
  3. Diagnostic Radiology Radiology $1,348 6% · 7 practitioners
  4. Vascular & Interventional Radiology Radiology $697 3% · 13 practitioners
  5. Neurological Surgery $665 3% · 11 practitioners

The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $5,632 26% · 40 recipients
  2. Florida $4,090 19% · 37 recipients
  3. Louisiana $2,923 14% · 11 recipients
  4. Texas $1,443 7% · 12 recipients
  5. California $837 4% · 4 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

1,549 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record